Molecule Information
General Information of the Molecule (ID: Mol01040)
Name |
Peptide methionine sulfoxide reductase MsrB (MSRB)
,Escherichia coli
|
||||
---|---|---|---|---|---|
Synonyms |
Peptide-methionine (R)-S-oxide reductase; yeaA; b1778; JW1767
Click to Show/Hide
|
||||
Molecule Type |
Protein
|
||||
Gene Name |
msrB
|
||||
Gene ID | |||||
Sequence |
MANKPSAEELKKNLSEMQFYVTQNHGTEPPFTGRLLHNKRDGVYHCLICDAPLFHSQTKY
DSGCGWPSFYEPVSEESIRYIKDLSHGMQRIEIRCGNCDAHLGHVFPDGPQPTGERYCVN SASLRFTDGENGEEING Click to Show/Hide
|
||||
Uniprot ID | |||||
Click to Show/Hide the Complete Species Lineage | |||||
Type(s) of Resistant Mechanism of This Molecule
UAPP: Unusual Activation of Pro-survival Pathway
Drug Resistance Data Categorized by Drug
Approved Drug(s)
1 drug(s) in total
Triclosan
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Unusual Activation of Pro-survival Pathway (UAPP) | ||||
Disease Class: Escherichia coli infection | [1] | |||
Resistant Disease | Escherichia coli infection [ICD-11: 1A03.0] | |||
Resistant Drug | Triclosan | |||
Molecule Alteration | Expression | Up-regulation |
||
Experimental Note | Discovered Using In-vivo Testing Model | |||
In Vitro Model | E. coli IFN4 | 562 | ||
Experiment for Molecule Alteration |
Microarray hybridization assay | |||
Experiment for Drug Resistance |
MIC assay | |||
Mechanism Description | A FabI NAD+ triclosan ternary complex is formed by face-to-face interaction between the phenol ring of triclosan and the nicotinamide ring of NAD+ in the active site of FabI (enoyl-acyl carrier protein reductase) and therefore highly expressed reductases (narGHJI, garR, hcp and yeaA) and dehydrogenases (fdnGHI, ykgEF, garD, gldA and yeiQ) could bind triclosan which were as the NAD(P) cofactor, thus lowering the effective triclosan concentration. |
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.